The Phase III trial started in December 2007 and there are about 129 trial locations scheduled to enroll 1250 patients and another trial that started at the same time schduled to enroll 800 patients at about 129 locations and two other trials as well.
If they started in December 2007 with 129 locations enrolling a few thousand Alzheimer's patients how long do you think it will take the FDA before they see actionable results.
Market Data 
Markets 
AI
